HK1248248A1 - 广谱抗感染肽 - Google Patents

广谱抗感染肽 Download PDF

Info

Publication number
HK1248248A1
HK1248248A1 HK18107687.3A HK18107687A HK1248248A1 HK 1248248 A1 HK1248248 A1 HK 1248248A1 HK 18107687 A HK18107687 A HK 18107687A HK 1248248 A1 HK1248248 A1 HK 1248248A1
Authority
HK
Hong Kong
Prior art keywords
infective peptides
infective
peptides
broad
spectrum anti
Prior art date
Application number
HK18107687.3A
Other languages
English (en)
Chinese (zh)
Inventor
赵南俊
趙南俊
约书亚‧亚历山大‧杰克曼
約書亞‧亞歷山大‧杰克曼
Original Assignee
南洋理工大学
南洋理工大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南洋理工大学, 南洋理工大學 filed Critical 南洋理工大学
Publication of HK1248248A1 publication Critical patent/HK1248248A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44—Guanidine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C07K14/1816—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
    • C07K14/1833—Hepatitis C; Hepatitis NANB
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Materials Engineering (AREA)
HK18107687.3A 2015-06-25 2016-06-24 广谱抗感染肽 HK1248248A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562184354P 2015-06-25 2015-06-25
US62/184,354 2015-06-25
PCT/SG2016/050291 WO2016209173A1 (en) 2015-06-25 2016-06-24 Broad-spectrum anti-infective peptides

Publications (1)

Publication Number Publication Date
HK1248248A1 true HK1248248A1 (zh) 2018-10-12

Family

ID=57586064

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107687.3A HK1248248A1 (zh) 2015-06-25 2016-06-24 广谱抗感染肽

Country Status (12)

Country Link
US (3) US10351604B2 (enExample)
EP (1) EP3313862B9 (enExample)
JP (2) JP6768012B2 (enExample)
KR (1) KR20180037185A (enExample)
CN (1) CN107922461A (enExample)
AU (1) AU2016281477A1 (enExample)
BR (1) BR112017028190A2 (enExample)
CA (1) CA2989399A1 (enExample)
HK (1) HK1248248A1 (enExample)
MX (1) MX2017016227A (enExample)
SG (1) SG10201912866RA (enExample)
WO (1) WO2016209173A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017028190A2 (pt) 2015-06-25 2018-09-04 Univ Nanyang Tech Peptídeo, peptídeo peguilado, composição, composição farmacêutica, frasco, solução de desinfecção, método para inibição de crescimento, replicação ou infectividade de um micro- organismo, método para inibição de crescimento bacteriano, método para inibição de replicação viral em uma célula, método para tratamento de uma infecção de micro-organismo em um sujeito e prevenção de uma doença em um sujeito causada por ou associada a uma infecção de micro- organismo, método para inibição de crescimento bacteriano em um sujeito, método para tratamento de uma infecção bacteriana em um sujeito e tratamento de uma doença causada por ou associada a uma infecção bacteriana, método para prevenção de uma doença causada por ou associada a uma infecção bacteriana em um sujeito, método para inibição de replicação viral em um sujeito, método para tratamento de uma infecção viral em um sujeito e tratamento de uma doença causada por ou associada a uma infecção viral em um sujeito, método para prevenção de uma doença causada por ou associada a uma infecção viral em um sujeito, método para desinfecção de um objeto inanimado ou material biológico e superfície inanimada ou superfície biológica
WO2020047203A2 (en) * 2018-08-30 2020-03-05 Osel, Inc. Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
US20230256049A1 (en) * 2020-07-24 2023-08-17 Oak Crest Institute Of Science Materials and methods for the prevention and treatment of viral respiratory diseases
WO2022220749A1 (en) * 2021-04-13 2022-10-20 Nanyang Technological University Anti-viral peptide compositions and methods to improve biological activity thereof
US20240197814A1 (en) * 2021-04-27 2024-06-20 Oak Crest Institute Of Science Materials and methods for the prevention and treatment of viral diseases
CN117756904B (zh) * 2023-12-22 2024-05-24 潍坊医学院 一种订书肽及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002259130A1 (en) * 2001-05-03 2002-11-18 Eli Lilly And Company Agents for treatment of hcv and methods of use
EP1357127A1 (de) * 2002-04-10 2003-10-29 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
EP1537418A2 (en) * 2002-09-13 2005-06-08 Intercell AG Method for isolating hepatitis c virus peptides
WO2004028563A1 (en) * 2002-09-27 2004-04-08 Genexine Inc. A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
NZ551319A (en) * 2004-05-17 2010-07-30 Novartis Vaccines & Diagnostic Truncated Hepatitis C virus NS5 domain and fusion proteins comprising same
US20070073039A1 (en) 2005-09-29 2007-03-29 Chisari Francis V Peptides that inhibit viral infections
TW200837075A (en) * 2007-01-10 2008-09-16 Scripps Research Inst Antiviral peptides
EP2508531B1 (en) * 2007-03-28 2016-10-19 President and Fellows of Harvard College Stitched polypeptides
WO2009014615A2 (en) * 2007-07-19 2009-01-29 The Board Of Trustees Of The Leland Stanford Junior University Amphipathic alpha-helical peptide compositions as antiviral agents
JP2011508785A (ja) 2008-01-03 2011-03-17 マサチューセッツ インスティテュート オブ テクノロジー デコイインフルエンザ処置
US8586707B2 (en) 2008-09-16 2013-11-19 The Research Foundation Of State University Of New York Stapled peptides and method of synthesis
RU2447899C2 (ru) 2010-05-27 2012-04-20 Михаил Валентинович Филатов Композиция для лечения гепатита с и способ лечения гепатита с
EP2763532B1 (en) * 2011-10-05 2018-09-19 The Board of Trustees of the Leland Stanford Junior University Pi-kinase inhibitors with broad spectrum anti-infective activity
BR112017028190A2 (pt) 2015-06-25 2018-09-04 Univ Nanyang Tech Peptídeo, peptídeo peguilado, composição, composição farmacêutica, frasco, solução de desinfecção, método para inibição de crescimento, replicação ou infectividade de um micro- organismo, método para inibição de crescimento bacteriano, método para inibição de replicação viral em uma célula, método para tratamento de uma infecção de micro-organismo em um sujeito e prevenção de uma doença em um sujeito causada por ou associada a uma infecção de micro- organismo, método para inibição de crescimento bacteriano em um sujeito, método para tratamento de uma infecção bacteriana em um sujeito e tratamento de uma doença causada por ou associada a uma infecção bacteriana, método para prevenção de uma doença causada por ou associada a uma infecção bacteriana em um sujeito, método para inibição de replicação viral em um sujeito, método para tratamento de uma infecção viral em um sujeito e tratamento de uma doença causada por ou associada a uma infecção viral em um sujeito, método para prevenção de uma doença causada por ou associada a uma infecção viral em um sujeito, método para desinfecção de um objeto inanimado ou material biológico e superfície inanimada ou superfície biológica

Also Published As

Publication number Publication date
US11866460B2 (en) 2024-01-09
JP2020040950A (ja) 2020-03-19
CN107922461A (zh) 2018-04-17
SG10201912866RA (en) 2020-02-27
JP6768012B2 (ja) 2020-10-14
US20180186837A1 (en) 2018-07-05
AU2016281477A1 (en) 2018-01-04
KR20180037185A (ko) 2018-04-11
US20200087349A1 (en) 2020-03-19
BR112017028190A2 (pt) 2018-09-04
EP3313862B1 (en) 2023-06-07
EP3313862A4 (en) 2019-01-23
US20220402972A1 (en) 2022-12-22
EP3313862A1 (en) 2018-05-02
CA2989399A1 (en) 2016-12-29
JP2018531880A (ja) 2018-11-01
US10351604B2 (en) 2019-07-16
WO2016209173A1 (en) 2016-12-29
MX2017016227A (es) 2019-03-28
EP3313862B9 (en) 2023-10-04

Similar Documents

Publication Publication Date Title
MX2017016227A (es) Peptidos anti-infecciosos de amplio espectro.
WO2016118014A3 (en) Anti-senescence compounds and uses thereof
HK1252759A1 (zh) 肽寡核苷酸缀合物
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
WO2011121289A3 (en) Peptides and their use
EP4349359A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
WO2016005328A3 (en) IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID ß (Aß) AMINO ACID SEQUENCES AND USES THEREOF
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
WO2017125585A3 (en) Novel polypeptides and medical uses thereof
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
PH12017500450A1 (en) Flavivirus virus like particle
WO2008093058A3 (en) Peptides and their use
WO2005082399A3 (en) Treatment of bacterial infections
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
EP4653537A3 (en) Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function
EP4406613A3 (en) Immunogenic arginase peptides
MX373912B (es) Terapias antibioticas peptidicas derivadas del bufalo de agua
WO2017211922A3 (en) Protease-resistant mono-lipidated peptides
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
WO2015198265A3 (en) Disinfectant and antimicrobial compositions, in particular for the veterinary field
EP3026057A3 (en) Compositions for prevention and treatment of neurodegenerative diseases
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use
GB2568440A (en) Modified factor H binding protein
CA3010564A1 (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition